Ikris Pharma Network

Exhibitor

About Ikris 

Just to inform we have a competent team of expert professionals and a robust global network of efficient supply chain which includes our pre-owned state-of-the-art warehouse in Belgium / Bulgaria . As you are well familiar that several promising medications from innovator companies like yours are either not available in India or they are still under registration. Regulatory approvals are time consuming and many a times lack of clinical trial data acts as double edged sword. There are seriously ill patients who have exhausted all the alternative treatment options. NPP (Named Patient Program) is the last option for such patients and their families. The process of Named Patient Import is cumbersome and requires expertise for documentation criss-crossed among:- company-physician-patient-payor-supplier etc. Besides knowledge & expertise is required for import documentation, customs clearance & duty exemptions etc. 

We are an expert company handling NPP for the last about a decade in India. Our team is well versed with Innovator Company Business Compliance, patient privacy & Pharmacovigilance. We are already supplying the medications through the Named Patient Import basis from our Belgium Warehouse to patients in India. Our Belgium & Bulgarian warehouse is EUGDP certified and we follow all the legal obligations, paperwork, invoicing & compliance We have team of Therapy Specialists spread across India covering all major hospitals in the country and having excellent rapport with KOLs in Super Specialty domain.

We are Proud Exclusive authorized providers for Rare Disease specialty medications of below-mentioned innovator companies in India (for the products not launched in India) :-  

1. Alexion :Strensiq 
2. Sarepta Therapeutics: Exondys 51 , VYONDYS 53 , AMONDYS 45
3. Recordati Rare disease: Carbaglu, Cystagon, Normosang, Pedea, Cystadrops
4. PTC Therapeutics: TRANSLARNA (ATALUREN)
5. BioMarin: Vimizim, Naglazyme, Kuvan, , Brineura , Voxzogo 
6. Servier Pharmaceuticals: Tibsovo and Oncaspar 

website